The present invention relates to the administration of compositions comprisingan antiestrogen, preferably trans-clomiphene,for treating metabolic syndrome in a subject. The invention is also directedto methods for reducing fasting glucoselevels in a subject by administering a composition comprising an antiestrogen,preferably trans-clomiphene.